How we treat advanced biliary tract cancers in the second-line setting
Clin Adv Hematol Oncol
.
2023 Jan;21(1):35-42.
Authors
Haley Ellis
1
2
,
Srivatsan Raghavan
1
2
,
Brian M Wolpin
1
2
,
James M Cleary
1
2
Affiliations
1
Dana-Farber Cancer Institute, Boston, Massachusetts.
2
Harvard Medical School, Boston, Massachusetts.
PMID:
36638354
No abstract available
MeSH terms
Bile Duct Neoplasms*
Biliary Tract Neoplasms* / drug therapy
Humans